Profile data is unavailable for this security.
About the company
Ascletis Pharma Inc is a China-based investment holding company principally engaged in the research, development, production, marketing and sales of pharmaceutical products. The Company mainly focuses on viral diseases, non-alcoholic steatohepatitis (NASH) and oncology fields. Viral diseases pipeline includes Ritonavir, Ravidasvir, Danoprevir and others. NASH pipeline includes ASC40, ASC41, ASC42 and others. Oncology pipeline includes ASC60, ASC61 and others.
- Revenue in HKD (TTM)61.00m
- Net income in HKD-155.98m
- Incorporated2014
- Employees219.00
- LocationAscletis Pharma Inc12F, Building D198 Qidi Road, HIPARKHANGZHOU ChinaCHN
- Websitehttps://www.ascletis.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jbm (Healthcare) Ltd | 610.30m | 97.99m | 800.46m | 258.00 | 8.84 | 0.8535 | 5.38 | 1.31 | 0.1087 | 0.1087 | 0.6786 | 1.12 | 0.4406 | 5.88 | 4.10 | 2,000,994.00 | 7.56 | 3.33 | 9.04 | 4.93 | 47.70 | 45.97 | 17.17 | 10.97 | 1.45 | 22.15 | 0.1211 | 13.81 | 28.11 | 14.51 | 131.90 | 6.14 | -5.09 | -- |
Zhaoke Ophthalmology Ltd | 20.21m | -415.00m | 813.75m | 313.00 | -- | 0.3686 | -- | 40.27 | -0.763 | -0.763 | 0.0372 | 4.04 | 0.0075 | -- | 0.531 | 64,565.83 | -15.43 | -- | -17.27 | -- | 75.98 | -- | -2,053.54 | -- | 5.32 | -47.54 | 0.1041 | -- | -- | -- | 5.47 | -- | -- | -- |
Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 907.03m | 159.74m | 840.38m | 848.00 | 5.26 | 0.5267 | 6.87 | 0.9265 | 0.2851 | 0.2851 | 1.62 | 2.85 | 0.3587 | 2.18 | 2.94 | 1,069,615.00 | 6.32 | 7.67 | 9.12 | 10.48 | 69.40 | 78.79 | 17.61 | 20.68 | 1.51 | -- | 0.0515 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
Fusen Pharmaceutical Co Ltd | 609.62m | -39.10m | 884.95m | 1.15k | -- | 1.46 | -- | 1.45 | -0.0524 | -0.0524 | 0.8106 | 0.8099 | 0.4199 | 1.95 | 8.36 | 531,030.40 | -2.69 | 0.9678 | -5.54 | 1.74 | 52.95 | 51.95 | -6.42 | 2.59 | 0.6096 | 0.756 | 0.3797 | 27.95 | 15.02 | 4.13 | -4.83 | -- | 0.2124 | -- |
Zhongzhi Pharmaceutical Holdings Ltd | 2.21bn | 175.44m | 889.51m | 2.64k | 4.97 | 0.7871 | 3.09 | 0.4026 | 0.2071 | 0.2071 | 2.61 | 1.31 | 1.12 | 2.53 | 10.54 | 835,916.00 | 8.95 | 7.69 | 14.15 | 11.75 | 59.73 | 60.44 | 8.01 | 6.73 | 0.894 | -- | 0.1424 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | 3.22 |
Brii Biosciences Ltd | 665.01k | -188.43m | 926.86m | 128.00 | -- | 0.2756 | -- | 1,393.74 | -0.259 | -0.259 | 0.0009 | 4.61 | 0.0002 | -- | -- | 5,195.42 | -5.60 | -- | -5.84 | -- | -- | -- | -29,881.69 | -- | -- | -- | 0.001 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
JW (Cayman) Therapeutics Co Ltd | 187.39m | -827.76m | 961.80m | 398.00 | -- | 0.5272 | -- | 5.13 | -2.01 | -2.01 | 0.4553 | 4.40 | 0.0704 | 1.68 | 65.54 | 470,817.30 | -31.11 | -39.77 | -35.21 | -44.00 | 50.74 | -- | -441.74 | -1,316.81 | 3.86 | -47.82 | 0.1592 | -- | 19.32 | -- | 9.23 | -- | -19.87 | -- |
Hbm Holdings Ltd | 699.15m | 178.08m | 1.05bn | 177.00 | 5.66 | 1.07 | 4.92 | 1.51 | 0.2422 | 0.2422 | 0.9526 | 1.28 | 0.3886 | 3.90 | 3.01 | 3,950,022.00 | 9.88 | -54.61 | 14.13 | -66.04 | 97.73 | 97.81 | 25.43 | -400.28 | 3.28 | 6.98 | 0.3556 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
Sunho Biologics Inc | -100.00bn | -100.00bn | 1.09bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -155.25 | -- | -- | -- |
Ascletis Pharma Inc | 61.00m | -155.98m | 1.14bn | 219.00 | -- | 0.4668 | -- | 18.76 | -0.1466 | -0.1466 | 0.0568 | 2.42 | 0.022 | 2.30 | 3.86 | 278,539.90 | -5.62 | -6.43 | -5.91 | -6.64 | 45.92 | 35.67 | -255.70 | -243.38 | 16.54 | -6.09 | 0.0036 | -- | 4.63 | -19.39 | 54.04 | -- | -20.44 | -- |
Jacobson Pharma Corporation Ltd | 1.68bn | 212.16m | 1.22bn | 1.59k | 5.48 | 0.5114 | 3.08 | 0.7249 | 0.1112 | 0.1409 | 0.8822 | 1.19 | 0.3722 | 2.87 | 7.50 | 940,829.50 | 5.16 | 4.91 | 6.61 | 6.60 | 42.05 | 41.81 | 13.85 | 14.32 | 1.01 | 5.62 | 0.3646 | 35.97 | 11.91 | 2.89 | 41.30 | 4.42 | -6.22 | 6.39 |
VIVA Biotech Holdings | 2.32bn | -125.15m | 1.34bn | 2.08k | -- | 0.3341 | 11.16 | 0.5768 | -0.0637 | -0.0637 | 1.20 | 1.86 | 0.2805 | 4.84 | 5.21 | 1,118,595.00 | -1.30 | -1.39 | -1.79 | -1.68 | 34.26 | 34.81 | -4.63 | -5.44 | 1.15 | 1.00 | 0.3412 | -- | -9.42 | 59.31 | 78.03 | -- | 31.98 | -- |
Jacobio Pharmaceuticals Group Co Ltd | 68.46m | -387.07m | 1.39bn | 301.00 | -- | 1.20 | -- | 20.24 | -0.5007 | -0.5007 | 0.0886 | 1.46 | 0.0419 | -- | 5.21 | 227,452.00 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
Wuhan YZY Biopharma Co Ltd | 0.00 | -206.62m | 1.44bn | 123.00 | -- | 10.50 | -- | -- | -1.11 | -1.11 | 0.00 | 0.7098 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.41 | -100.12 | 0.4138 | -- | -- | -- | -1.50 | -- | -- | -- |
Essex Bio-Technology Ltd | 1.71bn | 275.26m | 1.45bn | 1.48k | 5.44 | 0.7523 | 4.32 | 0.848 | 0.4689 | 0.4689 | 2.87 | 3.39 | 0.6161 | 2.28 | 3.35 | 1,152,300.00 | 9.94 | 11.20 | 13.21 | 14.73 | 90.20 | 86.01 | 16.13 | 19.77 | 1.46 | -- | 0.1326 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
Mabpharm Ltd | 93.94m | -225.65m | 1.51bn | 347.00 | -- | 6.81 | -- | 16.02 | -0.0547 | -0.0547 | 0.0228 | 0.0536 | 0.0893 | 0.1176 | 6.02 | 270,731.30 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
Data as of Jun 07 2024. Currency figures normalised to Ascletis Pharma Inc's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
E Fund Management Co., Ltd.as of 31 Dec 2023 | 7.89m | 0.78% |
Dimensional Fund Advisors LPas of 31 Jan 2024 | 3.58m | 0.35% |
JPMorgan Asset Management (China) Co Ltd.as of 31 Dec 2023 | 2.75m | 0.27% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.82m | 0.18% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 1.73m | 0.17% |
Fullgoal Asset Management (HK) Ltd.as of 30 Jun 2023 | 924.00k | 0.09% |
Dimensional Fund Advisors Ltd.as of 30 Apr 2024 | 327.67k | 0.03% |
SSgA Funds Management, Inc.as of 09 May 2024 | 200.00k | 0.02% |
American Century Investment Management, Inc.as of 09 May 2024 | 186.00k | 0.02% |
China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 45.00k | 0.00% |
More ▼
Data from 30 Jun 2023 - 06 Jun 2024Source: FactSet Research Systems Inc.